Literature DB >> 33369762

Determination of cardiac disease biomarker by plasmonic sandwich ELISA.

Weirong Wei1, Yinyan Tang2, Huimin He2, Subash C B Gopinath3,4, Lingling Wang1.   

Abstract

Acute myocardial infarction (AMI) is the heart attack happening when the blood flow is terminated to the heart muscles. C-reactive protein (CRP) level is raising significantly in AMI patients after the onset of symptom; also, temporal variations of CRP in plasma of AMI patient have also been found. Quantifying the concentration of CRP helps to identify the condition associated with AMI. Plasmonic enzyme-linked immunosorbent assay (ELISA) was utilized here to identify CRP by the sandwich of aptamer and antibody. Bare-eye CRP detection was achieved by plasmonic ELISA through the aggregation (blue color) of gold nanoparticle in the presence of CRP, whereas in the absence of CRP, it retains its red color (dispersion). Depending on the catalase presence on the ELISA surface, hydrogen peroxide (H2 O2 ) controls gold growth and differentiates with color changes. To achieve the lowest detection limit of CRP, H2 O2 (200 µM), gold seed (0.2 µM), and streptavidin-catalase (1:500) were found optimal. The detection limit was reached at 0.25 µg/mL, whereas it was 0.5 µg/mL in the CRP-spiked serum. This method of detection system is easier to detect the levels of CRP and helps diagnosing AMI.
© 2020 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  C-reactive protein; gold nanoparticle; myocardial infarction; plasmonic ELISA

Mesh:

Substances:

Year:  2021        PMID: 33369762     DOI: 10.1002/bab.2092

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  2 in total

Review 1.  Recent progress on bio-succinic acid production from lignocellulosic biomass.

Authors:  Jiasheng Lu; Jiawen Li; Hao Gao; Dawei Zhou; Huixin Xu; Yuexin Cong; Wenming Zhang; Fengxue Xin; Min Jiang
Journal:  World J Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 3.312

Review 2.  Diagnoses Based on C-Reactive Protein Point-of-Care Tests.

Authors:  Miroslav Pohanka
Journal:  Biosensors (Basel)       Date:  2022-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.